LLY vs MSFT
Eli Lilly and Company vs Microsoft Corporation
LLY
Eli Lilly and Company
$1077.19-0.35%
MSFT
Microsoft Corporation
$470.67-1.36%
Key Metrics Comparison
| LLY | Metric | MSFT |
|---|---|---|
| $1077.19 | Price | $470.67 |
| $967.62B | Market Cap | $3.50TBetter |
| 52.75 | P/E Ratio | 33.43Better |
| $20.42Better | EPS | $14.08 |
| -0.35%Better | Day Change | -1.36% |
| $1133.95 | 52W High | $555.45 |
| $623.78 | 52W Low | $344.79 |
| 1,798,219 | Volume | 27,617,535Better |
| 3,523,988 | Avg Volume | 23,349,227Better |
About Eli Lilly and Company
Healthcare | Drug Manufacturers - General
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, a...
About Microsoft Corporation
Technology | Software - Infrastructure
Microsoft Corporation develops, licenses, and supports software, services, devices, and solutions worldwide. The company operates in three segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment offers Office, Exc...